h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
LNISi002-B
Registration Summary
:
A
P
E
C
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
LNISi002-B
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
LNISi002-B (RRID:CVCL_D6IV)
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
11th April 2022
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Laboratory of NeuroImmunology (LNIS)
External Databases
Cellosaurus
CVCL_D6IV
Wikidata
Q127382619
General Information
Publications
Soldati S et al. High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitro. J Neuroinflammation. 2023-01-01.
Soldati S et al. High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4(+) T cell arrest on the inflamed BBB under flow in vitro. Journal of neuroinflammation. 2023 May 23;20(1):123.
Stüdle C et al. SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier. Fluids and barriers of the CNS. 2023 Oct 24;20(1):76.
Mathias A et al. Human stem cell-derived neurons and astrocytes to detect novel auto-reactive IgG response in immune-mediated neurological diseases. Frontiers in immunology. 2024;15:1419712.
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.